Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid With Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00293-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Comparison of Immunogenicity and Protection of Two Pneumococal Protein Vaccines Based on PsaA and PspA

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2018English

Recognition of Pneumococcal Isolates by Antisera Raised Against PspA Fragments From Different Clades

Journal of Medical Microbiology
MedicineMicrobiology
2008English

Diversity of Pneumococcal Surface Protein a (PspA) Among Prevalent Clones in Spain

BMC Microbiology
Microbiology
2009English

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice

Viruses
VirologyInfectious Diseases
2020English

Simultaneous Influenza and Pneumococcal Vaccines

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
1996English

Pneumococcal Surface Protein a Is Expressed in Vivo, and Antibodies to PspA Are Effective for Therapy in a Murine Model of Pneumococcal Sepsis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Pneumococcal Disease: Epidemiology and New Vaccines

Community Acquired Infection
2014English

Evidence That Prevention of Carriage by Pneumococcal Capsular Vaccines May Be the Mechanism of Protection From Pneumococcal Pneumonia

Southern African Journal of Epidemiology and Infection
DermatologyEpidemiologyInfectious Diseases
2011English

Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines

Pathogens
ImmunologyMolecular BiologyAllergyMicrobiologyMicrobiology Infectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy